Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) EBT Margin (2016 - 2025)

CorMedix (CRMD) has disclosed EBT Margin for 14 consecutive years, with 43.89% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 6034.0% to 43.89% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48.13% through Dec 2025, up 4872.0% year-over-year, with the annual reading at 48.13% for FY2025, 4872.0% up from the prior year.
  • EBT Margin hit 43.89% in Q4 2025 for CorMedix, down from 50.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 192678.48% in Q2 2023 to a low of 100538.67% in Q3 2022.
  • Historically, EBT Margin has averaged 9062.32% across 5 years, with a median of 24.24% in 2024.
  • Biggest five-year swings in EBT Margin: soared 23121636bps in 2023 and later tumbled -19443399bps in 2024.
  • Year by year, EBT Margin stood at 13814.54% in 2021, then tumbled by -100bps to 27637.7% in 2022, then skyrocketed by 369bps to 74310.64% in 2023, then plummeted by -100bps to 104.23% in 2024, then crashed by -58bps to 43.89% in 2025.
  • Business Quant data shows EBT Margin for CRMD at 43.89% in Q4 2025, 50.42% in Q3 2025, and 51.21% in Q2 2025.